Markets regulator Sebi has banned industrialist Anil Ambani from the securities market for five years after concluding that he engineered a fraudulent scheme to siphon off funds from Reliance Home Finance. Ambani had declared himself bankrupt before a UK court back in February 2020. In addition, the regulator fined Ambani a whooping Rs. 25 crore […]
According to Axis Securities, the pharma sector recorded 11% YoY and 4% QoQ revenue growth in Q1FY25, led by the strength of the home market, the introduction of new products, cost optimization, and the expansion of US businesses. The top choices are Lupin, Aurobindo Pharma, and Krishna Institute of Medical Sciences. According to a recent
Axis Securities has selected pharma stocks such as Lupin, KIMS, and Aurobindo Pharma Read More »
Only when it receives the appropriate valuation will Hindalco Industries list Novelis, its US-based business, according to managing director Satish Pai. Our primary goal in doing this IPO was to secure a higher valuation for Novelis. After the company’s most recent quarterly reporting, Pai told investors, “I think what was clear is that we were
MD: Hindalco will only float Novelis at its preferred valuation Read More »
After the business announced the introduction of its updated Jupiter 110 two-wheeler on Thursday, shares of TVS Motor business jumped 4% on Friday to reach a new all-time high of Rs 2,818 on the BSE. Subsequently, the international brokerage house UBS increased its target price of Rs 3,200 for the shares, signifying an 18% potential
In the most recent semi-annual September rejig of NSE indices, Vodafone Idea was removed from both the Nifty 500 and the Nifty Midcap 100. Vodafone Idea shares fell 2.35 percent on Friday (August 23) to settle at Rs 15.82 apiece on the NSE. The company’s current market capitalization is Rs 1,07,655.91 crore, with a free-float
NSE rejig: Vodafone Idea To depart Nifty 500 And Nifty Midcap 100 Read More »
Jerome Powell, the chair of the Federal Reserve, made it abundantly evident on Friday that safeguarding the labor market was now the central bank’s top priority and that it would not hesitate to switch to interest rate reductions in the closing weeks of a presidential election campaign. Federal Reserve’s Battle With Inflation The Federal Reserve’s
The Competition Commission of India (CCI) has been consulted by Tata Capital Ltd (TCL) over its bid to acquire Tata Motors Finance Ltd (TMFL). “The proposed transaction involves the merger of TMFL with and into TCL, with TCL being the surviving entity through a scheme of arrangement to be filed with the National Company Law
CCI approval is required for Tata Motors Finance and Tata Capital to unite Read More »
During its meeting on August 29, the board of the Indian Renewable Energy Development Agency (IREDA) is expected to consider a proposal to raise Rs 4,500 crore in one or more tranches through a follow-on public offer (FPO) or other modes. As a result, shares of IREDA surged nearly 9% to Rs 259.3 in Thursday’s
Bond yields decreased in response to a dramatic downward revision of US payroll data, which reinforced predictions that the Federal Reserve would cut interest rates in September. The rise in treasuries throughout the curve was driven by shorter maturities. Swap dealers are pricing in a 100 basis point decrease in 2024. The indicated rate on
As Jobs “Seal the Deal” for Fed Cut, US Yields Drop Read More »
 With data suggesting that US employment growth was likely significantly less strong in the year through March than previously reported, investors began to evaluate the outlook for interest rates, which led to a rise in European shares. By the end, the Stoxx Europe 600 had gained 0.3%. The industries with the largest gains were resources,
European Stocks Rise as Traders Consider the Chance of Fed Rate Reductions Read More »
We strongly advise against making investment decisions based solely on the target prices mentioned on this website. These target prices are merely predictions, and investing in the stock market inherently involves risk. The information provided on this site is intended for informational and educational purposes only and should not be considered financial advice or recommendations for any stock.